🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the efficacy, safety and tolerabili...
Status
Terminated
Location
University of Connecticut Health Center
Start Date
2017-07-18
Trial ID
NCT03234465
Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Status
Recruiting
Location
Research Site
Start Date
2023-07-28
Trial ID
NCT06068049
Patients with loco-regional NSCLC planned for curative treatment with chemo...
Status
Recruiting
Location
Odense University Hospital
Start Date
2015-08
Trial ID
NCT05258448
Treatments Being Tested
The PACIFIC study established the standard of care for immunotherapy consol...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-01
Trial ID
NCT07235306
Treatments Being Tested
The investigators conducted a phase II, prospective, two-arm clinical study...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2023-05-25
Trial ID
NCT05821452
Treatments Being Tested
The purpose of this study is to determine whether markers on tumor tissue m...
Status
Withdrawn
Location
St. Claraspital, Chirurgische Klinik
Start Date
2005-04
Trial ID
NCT00835055
This study is designed to investigate whether adjuvant radiochemotherapy af...
Status
Withdrawn
Location
Kailiang Wu
Start Date
2023-12-01
Trial ID
NCT02633514
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
This is a prospective, multi-center, single arm study assessing the efficac...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-01-21
Trial ID
NCT04982549
Treatments Being Tested
This study is to evaluate the efficacy and safety of AK104 plus concurrent ...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Start Date
2022-06-21
Trial ID
NCT05235516